Scarica l'app Stockscreener
31.54
2.44%
-0.79
Dopo l'orario di chiusura:
31.43
-0.11
-0.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$32.33
Aprire:
$31.59
Volume 24 ore:
1.43M
Relative Volume:
1.01
Capitalizzazione di mercato:
$13.27B
Reddito:
$6.18B
Utile/perdita netta:
$626.40M
Rapporto P/E:
21.98
EPS:
1.435
Flusso di cassa netto:
$848.81M
1 W Prestazione:
+3.17%
1M Prestazione:
+9.48%
6M Prestazione:
-7.62%
1 anno Prestazione:
+3.21%
Intervallo 1D:
$31.20
$31.59
Intervallo di 1 settimana:
$30.75
$32.76
Portata 52W:
$28.55
$38.79
Smith Nephew Plc Adr Stock (SNN) Company Profile
Nome
Smith Nephew Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare SNN vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
31.53 | 13.10B | 6.18B | 626.40M | 848.81M | 1.435 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-15 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-14 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-03-12 | Downgrade | UBS | Buy → Neutral |
| 2024-11-06 | Downgrade | Berenberg | Buy → Hold |
| 2024-11-01 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-07-24 | Iniziato | Deutsche Bank | Buy |
| 2024-06-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-11-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2023-11-03 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-10-31 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2023-10-13 | Iniziato | Stifel | Hold |
| 2023-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2023-04-27 | Downgrade | HSBC Securities | Buy → Hold |
| 2023-04-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | Iniziato | Citigroup | Buy |
| 2022-11-28 | Downgrade | UBS | Neutral → Sell |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-07-28 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-03-04 | Aggiornamento | Redburn | Sell → Neutral |
| 2021-06-09 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | Iniziato | Barclays | Overweight |
| 2020-07-29 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2020-06-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | Downgrade | Citigroup | Buy → Neutral |
| 2019-11-21 | Iniziato | Citigroup | Buy |
| 2019-11-12 | Iniziato | Bernstein | Outperform |
| 2019-07-23 | Aggiornamento | Berenberg | Hold → Buy |
| 2019-02-08 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-12-10 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | Reiterato | Canaccord Genuity | Buy |
| 2018-01-25 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-12-11 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-27 | Downgrade | Goldman | Buy → Neutral |
| 2017-01-19 | Iniziato | HSBC Securities | Hold |
| 2016-12-08 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | Downgrade | Berenberg | Buy → Hold |
| 2016-02-26 | Iniziato | Cantor Fitzgerald | Hold |
Mostra tutto
Smith Nephew Plc Adr Borsa (SNN) Ultime notizie
Smith & Nephew Advances $250 Million Share Buyback, Repurchasing Over 1 Million Shares in Latest Week - Kalkine Media
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care - Sahm
Smith & Nephew (NYSE: SNN) leaders buy ADS through employee stock plan - Stock Titan
Smith & Nephew Executives Acquire American Depositary Shares via Employee Stock Purchase Plan on July 10, 2026 - Kalkine Media
REGSmith & Nephew PlcDirector/PDMR Shareholding - TradingView
Smith+Nephew introduces groundbreaking LYNX™ COBLATION™ Laryngeal Wand for ENT surgeons - Sahm
Smith+Nephew introduces groundbreaking LYNX COBLATION Laryngeal Wand for ENT surgeons - Finviz
How Are Smith & Nephew (LSE:SN.) And ConvaTec (LSE:CTEC) Steering UK MedTech Sentiment? - Kalkine Media
SNN stock holds steady as Smith & Nephew keeps its investor focus - AD HOC NEWS
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR - GlobeNewswire Inc.
Why Is Smith & Nephew (LSE:SN.) Stock Being Watched After an Activist Investor Move? - Kalkine Media
Smith & Nephew plc ADR highlights its medical technology portfolio as investors weigh long-term grow - ad-hoc-news.de
Smith & Nephew plc (NYSE:SNN) Caviar Cruise Screen Analysis - ChartMill
REGENETEN bioinductive implant from Smith & Nephew plcshoulder tendon repair with a quiet patch - Ad-hoc-news.de
ALLEVYN COMPLETE CARE Foam Dressing from Smith & Nephew plcnext-generation comfort for demanding - AD HOC NEWS
NPWA Forecast — Price Target — Prediction for 2027 - TradingView
Smith & Nephew consensus in focus, analysts keep a cautious hold on the shares - AD HOC NEWS
939163 Forecast — Price Target — Prediction for 2027 - TradingView
India Advanced Wound Dressing Market Size & Outlook, 2033 - Grand View Research
Smith & Nephew strategy under new CEO, shares trade stable in London - AD HOC NEWS
Smith & Nephew StockThursday technical picture and trading range - ad-hoc-news.de
Why Smith & Nephew’s PICO Single Use Negative Pressure System is changing tricky wound care - AD HOC NEWS
Why Smith & Nephew’s LEGION Revision Knee still matters in tough cases - AD HOC NEWS
Smith+Nephew announces first clinical cases with the next generation CORI◊XT Handheld Robotics Platform across knee and shoulder arthroplasty - Sahm
Smith & Nephew plc (ADR) stock (US83175M2052): U.K. medtech group draws interest after recent debt m - AD HOC NEWS
Smith & Nephew (NYSE: SNN) execs add ADS via dividend reinvestment - Stock Titan
Dell Upgraded, Costco Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew launch next generation LEAF™ Patient Monitoring System – an innovative pressure injury prevention platform delivering proven clinical impact - Sahm
SNNSmith & Nephew plc ADR Stock Price and Quote - Finviz
Smith & Nephew plc stock (GB0009223206): orthopedics specialist lifts guidance after solid Q1 - AD HOC NEWS
Smith & Nephew stock (GB0009223206): sets sterling final dividend ahead of May payout - AD HOC NEWS
DowngradesStock ScreenerSnapshot - Finviz
Smith+Nephew’s REGENETEN◊ Bioinductive Implant shows post-operative recovery times halved, and high healing rates for partial-thickness rotator cuff tears1,* - Sahm
New data for Smith+Nephew’s CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant demonstrates superior pain relief and functional gains at 5-years - ChartMill
Smith & Nephew plc (ADR) stock (US83175M2052): Why Google Discover changes matter more now for medte - AD HOC NEWS
Smith & Nephew plc (ADR) stock (US83175M2052): Why its medtech innovation edge is suddenly worth a c - AD HOC NEWS
Smith & Nephew PLC (NYSE:SNN) Passes the Caviar Cruise Screen for Quality Investing - ChartMill
Smith & Nephew plc (ADR) Stock: Global Medtech Leader Faces Evolving Orthopedics and Sports Medicine - AD HOC NEWS
Smith & Nephew plc (ADR) stock faces pressure amid regulatory hurdles and slowing ortho demand - AD HOC NEWS
Smith & Nephew plc (ADR) Stock (ISIN: US83175M2052) Faces Headwinds Amid Medtech Sector Slowdown - AD HOC NEWS
Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - Finviz
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - ChartMill
NVIDIA Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Sahm
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - Sahm
Smith Nephew Plc Adr Azioni (SNN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):